Sameer Gadani, Jirapa Chansangrat, Baljendra Kapoor, Aaron McBride, Sasan Partovi, Nancy Obuchowski, David Choon Hyuck Kwon, Federico Aucejo, Abraham Levitin
{"title":"Liver Vein Deprivation versus Portal Vein Embolization: Retrospective Review of Safety and Effectiveness.","authors":"Sameer Gadani, Jirapa Chansangrat, Baljendra Kapoor, Aaron McBride, Sasan Partovi, Nancy Obuchowski, David Choon Hyuck Kwon, Federico Aucejo, Abraham Levitin","doi":"10.1016/j.jvir.2024.09.025","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To compare the safety and effectiveness of liver vein deprivation (LVD) and portal vein embolization (PVE) in patients scheduled to undergo liver resection.</p><p><strong>Materials and methods: </strong>This retrospective cohort study included 59 patients who underwent either PVE (n = 28) or LVD (n = 31) in preparation for liver resection. The primary outcome was percent change in future liver remnant volume (FLRV). The secondary endpoints were degree of hypertrophy (DH) and kinetic growth rate (KGR).</p><p><strong>Results: </strong>Low baseline FLRV and time interval in days between the procedure and follow-up imaging (Ti) positively impacted the primary and secondary endpoints in both groups. Percent change in FLRV was higher in the LVD group (52.8% ± 5.3) than in the PVE group (22.3% ± 3.0, P < .001). DH was also higher in the LVD group (15.4% ± 1.7) than in the PVE group (6.4% ± 0.9, P < .001). KGR did not differ significantly between groups (LVD, 0.54%/d ± 0.06; PVE, 0.35%/d ± 0.1; P = .239). When patients with a baseline standardized FLRV of >35% were excluded from the analysis, the LVD group demonstrated higher values than the PVE group in KGR (0.57%/d ± 0.06 vs 0.29%/d ± 0.05, P < .001), percent change in FLRV (64.2% ± 6.0 vs 25.9% ± 4.3, P < .001), and DH (15.4% ± 1.4 vs 6.6% ± 1.0, P < .001). No adverse events were noted in either group.</p><p><strong>Conclusions: </strong>LVD appears to be safe and may be superior to PVE in inducing hypertrophy of future liver remnant in patients scheduled to undergo surgical resection.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular and Interventional Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jvir.2024.09.025","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To compare the safety and effectiveness of liver vein deprivation (LVD) and portal vein embolization (PVE) in patients scheduled to undergo liver resection.
Materials and methods: This retrospective cohort study included 59 patients who underwent either PVE (n = 28) or LVD (n = 31) in preparation for liver resection. The primary outcome was percent change in future liver remnant volume (FLRV). The secondary endpoints were degree of hypertrophy (DH) and kinetic growth rate (KGR).
Results: Low baseline FLRV and time interval in days between the procedure and follow-up imaging (Ti) positively impacted the primary and secondary endpoints in both groups. Percent change in FLRV was higher in the LVD group (52.8% ± 5.3) than in the PVE group (22.3% ± 3.0, P < .001). DH was also higher in the LVD group (15.4% ± 1.7) than in the PVE group (6.4% ± 0.9, P < .001). KGR did not differ significantly between groups (LVD, 0.54%/d ± 0.06; PVE, 0.35%/d ± 0.1; P = .239). When patients with a baseline standardized FLRV of >35% were excluded from the analysis, the LVD group demonstrated higher values than the PVE group in KGR (0.57%/d ± 0.06 vs 0.29%/d ± 0.05, P < .001), percent change in FLRV (64.2% ± 6.0 vs 25.9% ± 4.3, P < .001), and DH (15.4% ± 1.4 vs 6.6% ± 1.0, P < .001). No adverse events were noted in either group.
Conclusions: LVD appears to be safe and may be superior to PVE in inducing hypertrophy of future liver remnant in patients scheduled to undergo surgical resection.
期刊介绍:
JVIR, published continuously since 1990, is an international, monthly peer-reviewed interventional radiology journal. As the official journal of the Society of Interventional Radiology, JVIR is the peer-reviewed journal of choice for interventional radiologists, radiologists, cardiologists, vascular surgeons, neurosurgeons, and other clinicians who seek current and reliable information on every aspect of vascular and interventional radiology. Each issue of JVIR covers critical and cutting-edge medical minimally invasive, clinical, basic research, radiological, pathological, and socioeconomic issues of importance to the field.